{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T14:21:48Z","timestamp":1781706108362,"version":"3.54.5"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>There has been substantial research conducted recently on the effect of myo-inositol (MI) on human reproduction. However, it still remains ambiguous about the therapeutic efficacy of MI in infertile women undergoing <jats:italic>in vitro<\/jats:italic> fertilization embryo transfer (IVF-ET). This systematic review and meta-analysis was carried out to investigate the efficacy of MI on IVF outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Literatures were searched in the PubMed, Web of Science, Cochrane Library, ScienceDirect and Wanfang databases. The methodological quality was assessed using the Cochrane Risk of Bias tool. Data were pooled using a random- or fixed-effects model according to study heterogeneity. The results are expressed as odds ratio (OR) or mean difference (MD) with 95% confidence intervals (CIs). Heterogeneity was measured by the I<jats:sup>2<\/jats:sup> statistic. The protocol was prospectively registered with PROSPERO (CRD42024582149).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Eleven eligible studies with 981 participants reported the IVF outcomes of the MI group versus the control group. The synthesis results showed that the metaphase II (MII) oocyte rate was higher in the MI group than in the control group (OR 1.55, 95% CI 1.04-2.31, <jats:italic>P<\/jats:italic>=0.03). For polycystic ovary syndrome (PCOS) women, as well as non-obese PCOS women, a statistically significant improvement in MII oocyte rate were assumed after taking MI (OR 1.97, 95% CI 1.20-3.25, <jats:italic>P<\/jats:italic>&amp;lt;0.01; OR 1.92, 95% CI 1.09-3.37, <jats:italic>P<\/jats:italic>=0.02) while there is no statistically significant advancement showed in the poor ovary responder (POR) women(OR 0.97, 95% CI 0.35-2.68, <jats:italic>P<\/jats:italic>=0.95). The fertilization rate was higher in the MI group than in the control group (OR 1.62, 95% CI 1.21-2.16, <jats:italic>P<\/jats:italic>&amp;lt;0.01), for PCOS, non-obese PCOS and POR women (OR 1.59, 95% CI 1.16-2.18, <jats:italic>P<\/jats:italic>&amp;lt;0.01; OR 1.87, 95% CI 1.52-2.31, <jats:italic>P<\/jats:italic>&amp;lt;0.01; OR 2.42, 95% CI 1.48-3.95, <jats:italic>P<\/jats:italic>&amp;lt;0.01).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our results suggest that MI supplementation improves the MII oocyte rate and the fertilization rate. More high-grade evidence from prospective randomized studies is warranted.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic review registration<\/jats:title><jats:p><jats:uri>https:\/\/www.crd.york.ac.uk\/PROSPERO\/<\/jats:uri>, identifier CRD42024582149.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1520362","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T05:18:35Z","timestamp":1742534315000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Effect of myo-inositol supplementation in mixed ovarian response IVF cohort: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"16","author":[{"given":"Jianeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanhuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianhua","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2011.02.001","article-title":"The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting","volume":"22","year":"2011","journal-title":"Hum Reprod"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dead184","article-title":"Good practice recommendations on add-ons in reproductive medicine","volume":"38","author":"Lundin","year":"2023","journal-title":"Hum Reprod"},{"key":"B3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/humupd\/dmq029","article-title":"Predictive value of oocyte morphology in human IVF: a systematic review of the literature","volume":"17","author":"Rienzi","year":"2011","journal-title":"Hum Reprod Update"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/0028-2243(89)90215-3","article-title":"The influence of oocyte maturity and embryo quality on pregnancy rate in a program for in vitro fertilization-embryo transfer","volume":"52","author":"Hill","year":"1989","journal-title":"Fertil Steril"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/des427","article-title":"Semi-automated morphometric analysis of human embryos can reveal correlations between total embryo volume and clinical pregnancy","volume":"28","author":"Paternot","year":"2013","journal-title":"Hum Reprod"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoad023","article-title":"ESHRE good practice recommendations on recurrent implantation failure","volume":"3","author":"Cimadomo","year":"2023","journal-title":"Hum Reprod Open"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1038\/s41598-021-81439-6","article-title":"Efficacy of therapies and interventions for repeated embryo implantation failure: a systematic review and meta-analysis","volume":"11","author":"Busnelli","year":"2021","journal-title":"Sci Rep"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/jez.1402450211","article-title":"The effects of water-soluble vitamins on the expansion of rabbit blastocysts in vitro","volume":"245","author":"Kane","year":"1988","journal-title":"J Exp Zool"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/17.6.1591","article-title":"Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality","volume":"17","author":"Chiu","year":"2002","journal-title":"Hum Reprod"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/BF01204248","article-title":"A correlation of the outcome of clinical in vitro fertilization with the inositol content and embryo trophic properties of human serum","volume":"9","author":"Chiu","year":"1992","journal-title":"J Assist Reprod Genet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1186\/s12978-021-01073-3","article-title":"Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies","author":"Merviel","year":"2021","journal-title":"Reprod Health"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1042\/bst0170259","article-title":"The cellular functions of myo-inositol","volume":"17","author":"Downes","year":"1989","journal-title":"Biochem SocTrans"},{"key":"B13","article-title":"Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial","volume":"7","author":"Gerli","year":"2003","journal-title":"Eur Rev Med Pharmacol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2011.564687","article-title":"Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oocyte quality: a prospective, longitudinal, cohort study","volume":"27","author":"Unfer","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"B16","article-title":"Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial","volume":"15","author":"Unfer","year":"2011","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2017.07.005","article-title":"Inositol supplementation in women with polycystic ovary syndrome undergoing intracytoplasmic sperm injection: a systematic review and meta-analysis of randomized controlled trials","volume":"35","author":"Mendoza","year":"2017","journal-title":"Reprod BioMed Online"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1186\/1757-2215-5-14","article-title":"Does ovary need D-chiro-inositol","volume":"5","author":"Isabella","year":"2012","journal-title":"J Ovarian Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-10-52","article-title":"Pretreatment with myo-inositol in non polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: a pilot study","volume":"10","author":"Lisi","year":"2012","journal-title":"Reprod Biol Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2015.09.024","article-title":"Results from the International Consensus Conference on Myo-inositol and d-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOS","volume":"31","author":"Facchinetti","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nature05185","article-title":"Phosphoinositides in cell regulation and membrane dynamics","volume":"443","author":"Gilbert","year":"2006","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1210\/me.2010-0297","article-title":"FSH and its second messenger cAMP stimulate the transcription of human anti-M\u00fcllerian hormone in cultured granulosa cells","volume":"25","author":"Jo\u00eblle","year":"2011","journal-title":"Mol Endocrinol"},{"key":"B23","unstructured":"Core software for Cochrane Reviews"},{"key":"B24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12958-021-00741-0","article-title":"The effect of Myo-inositol on fertility rates in poor ovarian responder in women undergoing assisted reproductive technique: a randomized clinical trial","volume":"19","author":"Mohammadi","year":"2021","journal-title":"Reprod Biol Endocrinol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2020.101698","article-title":"Effect of myo-inositol supplementation on ICSI outcomes among poor ovarian responder patients: A randomized controlled trial","volume":"49","author":"Nazari","year":"2020","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"B26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13048-015-0167-x","article-title":"Myo-inositol therapy for poor-responders during IVF: a prospective controlled observational trial","volume":"8","author":"Caprio","year":"2015","journal-title":"J Ovarian Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.12891\/ceog4567.2019","article-title":"Myoinositol supplementation on intracytoplasmic sperm injection outcome in Japanese infertile polycystic ovarian syndrome women with non-obese less-androgenic phenotype: a prospective controlled observational study","volume":"4","author":"Kitaya","year":"2019","journal-title":"Clin Exp Obstetrics Gynecol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-021-06833-9","article-title":"The effect of Myo-Inositol supplement on molecular regulation of folliculogenesis, steroidogenesis, and assisted reproductive technique outcomes in patients with polycystic ovarian syndrome","volume":"49","author":"Tabatabaie","year":"2022","journal-title":"Mol Biol Rep"},{"key":"B29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3109\/09513590.2015.1101444","article-title":"Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome","volume":"32","author":"Pacchiarotti","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.01.088","article-title":"Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial","volume":"91","author":"Papaleo","year":"2009","journal-title":"Fertil Steril"},{"key":"B31","article-title":"Effects of Myo-Inositol supplementation on oocyte\u2019s quality in PCOS patients: A double blind trial","volume":"15","author":"Ciotta","year":"2011","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-019-05111-1","article-title":"The myo-inositol effect on the oocyte quality and fertilization rate among women with polycystic ovary syndrome undergoing assisted reproductive technology cycles: a randomized clinical trial","volume":"299","author":"Akbari Sene","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"B33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1155\/2016\/4378507","article-title":"Prospective randomized study on the influence of myoinositol in PCOS women undergoing IVF in the improvement of oocyte quality, fertilization rate, and embryo quality","author":"Lesoine","year":"2016","journal-title":"Int J Endocrinol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1301\/00296640260042748","article-title":"Involvement of inositol in reproduction","volume":"60","author":"Beemster","year":"2002","journal-title":"Nutr Rev"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/4987436","article-title":"How to achieve high-quality oocytes? The key role of myo-inositol and melatonin","volume":"8085","author":"Vitale","year":"2016","journal-title":"Int J Endocrinol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/mrd.1080340407","article-title":"Incorporation of [3H]inositol into phosphoinositides and inositol phosphates by rabbit blastocysts","volume":"34","author":"Fahy","year":"1993","journal-title":"Mol Reprod Dev"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.02387","article-title":"Inositol-lipid binding motifs: Signal integrators through protein-lipid and protein-protein interactions","volume":"118","author":"Balla","year":"2005","journal-title":"J Cell Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1995.tb26646.x","article-title":"Inositol trisphosphate and calcium signaling","volume":"361","author":"Berridge","year":"1993","journal-title":"Ann NY Acad Sci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/8.10.912","article-title":"Inositol 1,4,5-trisphosphate receptor function in human oocytes: calcium responses and oocyte activation-related phenomena induced by photolytic release of InsP(3) are blocked by a specific antibody to the type I receptor","volume":"8","author":"Goud","year":"2002","journal-title":"Mol Hum Reprod"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1080\/09513590903015544","article-title":"Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome","volume":"25","author":"Zacche","year":"2009","journal-title":"Gynecol Endocrinol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod.109.076760","article-title":"Involvement of phospholipase C-related inactive protein in the mouse reproductive system through the regulation of gonadotropin levels","volume":"81","author":"Matsuda","year":"2009","journal-title":"Biol Reprod"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod.108.072538","article-title":"Maturation, fertilization, and the structure and function of the endoplasmic reticulum in cryopreserved mouse oocytes","volume":"81","author":"Lowther","year":"2009","journal-title":"Biol Reprod"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-013-2855-3","article-title":"The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial","volume":"288","author":"Colazingari","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deg113","article-title":"Effects of myo-inositol on the in-vitro maturation and subsequent development of mouse oocytes","volume":"18","author":"Tak","year":"2003","journal-title":"Hum Reprod"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-014-0188-1","article-title":"Improvement of mouse embryo quality by myo-inositol supplementation of IVF media","volume":"31","author":"Colazingari","year":"2014","journal-title":"J Assist Reprod Genet"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.18502\/jri.v21i4.4330","article-title":"The effect of preincubation time and myo-inositol supplementation on the quality of mouse MII oocytes","volume":"21","author":"Mohammadi","year":"2020","journal-title":"J Reprod Infertil"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e3154","DOI":"10.1002\/dmrr.3154","article-title":"Inositol and antioxidant supplementation: Safety and efficacy in pregnancy","volume":"35","author":"Formoso","year":"2019","journal-title":"Diabetes Metab Res Rev"},{"key":"B48","doi-asserted-by":"publisher","first-page":"i2","DOI":"10.1093\/humrep\/des200","article-title":"The oocyte","volume":"27","author":"Rienzi","year":"2012","journal-title":"Hum Reprod"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1520362\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T05:18:43Z","timestamp":1742534323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1520362\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":48,"alternative-id":["10.3389\/fendo.2025.1520362"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1520362","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,21]]},"article-number":"1520362"}}